NCT02067780View on ClinicalTrials.gov

Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPD

PHASE3CompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Levofloxacin 500mg

One tablet per day for 7days.

Trial Locations (1)

5000

Emergency department of university hospital Fattouma Bourguiba of Monastir, Monastir

All Listed Sponsors
lead

University of Monastir

OTHER

NCT02067780 - Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPD | Biotech Hunter | Biotech Hunter